NFE2L2 and cancer: In a series of analyses utilizing chemical carcinogenesis of the mouse lung and esophagus, we identified that systemic activation of NRF2 in mice, both genetic and pharmacological, improves the survival of the mice with NRF2-addicted cancers [87,98,134].